Please Note:

The Open Access Repository will be moving to a new authentication system on the 1st of November.

From this date onwards, account holders will be required to login using their University of Tasmania credentials.
If your current repository username differs from your University username, please email E.Prints@utas.edu.au so we can update these details on your behalf.

Due to the change, there will be a short outage of the repository from 9am on the morning of the 1st of November

Open Access Repository

Vaccination strategies for Alzheimer's disease: a new hope?

Downloads

Downloads per month over past year

Woodhouse, A and Dickson, TC and Vickers, JC (2007) Vaccination strategies for Alzheimer's disease: a new hope? Drugs and Aging, 24 (2). pp. 107-119. ISSN 1170-229X

[img] PDF
3996.pdf | Request a copy
Full text restricted
Available under University of Tasmania Standard License.

Abstract

The pathological hallmarks of Alzheimer’s disease (AD) include β-amyloid
(Aβ) plaques, dystrophic neurites and neurofibrillary pathology, which eventually
result in the degeneration of neurons and subsequent dementia. In 1999, international
interest in a new therapeutic approach to the treatment of AD was ignited
following transgenic mouse studies that indicated that it might be possible to
immunise against the pathological alterations in Aβ that lead to aggregation of this
protein in the brain. A subsequent phase I human trial for safety, tolerability and
immunogenicity using an active immunisation strategy against Aβ had a positive
outcome. However, phase IIA human trials involving active immunisation were
halted following the diagnosis of aseptic meningoencephalitis in 6% of
immunised subjects. Research into immunisation strategies involving transgenic
AD mouse models has subsequently been refocused to determine the mechanisms
by which plaque clearance and reduced memory deficits are attained, and to
establish safer therapeutic approaches that may reduce potentially harmful brain
inflammation. The vigour of international research on immunotherapy for AD
provides significant hope for a strong therapeutic lead for the escalating number of
individuals who will develop this otherwise incurable condition.

Item Type: Article
Journal or Publication Title: Drugs and Aging
Publisher: Adis International Ltd.
Page Range: pp. 107-119
ISSN: 1170-229X
Date Deposited: 07 Apr 2008 14:16
Last Modified: 18 Nov 2014 03:34
Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page
TOP